{
  "openalex_id": "W2954046467",
  "doi": "https://doi.org/10.1158/1538-7445.am2019-3597",
  "title": "Abstract 3597: BAY 2402234: Preclinical evaluation of a novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of diffuse large B-cell lymphoma (DLBCL)",
  "abstract": "Abstract DLBCL is the most common type of non-Hodgkin lymphoma. It is an aggressive and fast growing tumor with two major molecular subtypes: germinal center (GCB) and activated B-cell like (ABC). While the majority of patients are 60 years or older, DLBCL can occur at any age. Despite a cure rate of around 50% the need for novel therapies remains high, especially for relapsed/refractory DLBCL patients not eligible for stem cell transplant. DHODH is a key enzyme in the de novo pyrimidine synthesis converting dihydroorotate to orotate. We recently discovered its role in AML differentiation (Sykes et al 2016, Cell) and we are investigating the novel DHODH inhibitor BAY 2402234 in an ongoing phase I study in myeloid malignancies (NCT03404726). Further screening of non-leukemia cancer types identified DLBCL as highly responsive to DHODH inhibition in preclinical studies. Here, we disclose for the first time the functional preclinical characterization of BAY 2402234 in DLBCL. BAY 2402234 is a selective low-nanomolar inhibitor of human DHODH enzymatic activity. In vitro it potently inhibits proliferation of DLBCL cell lines in the sub-nanomolar to low-nanomolar range. The anti-proliferative effects can be rescued by uridine supplementation which bypasses DHODH via the salvage pathway and demonstrates the on-target specificity of the inhibitor. In vivo, BAY 2402234 exhibits strong in vivo anti-tumor efficacy in monotherapy in subcutaneous models derived from patient-derived xenograft (PDX) and cell lines representing various DLBCL subtypes, including GCB and ABC. Dose dependent target engagement and drug exposure of BAY 2402234 could be observed by increases in plasma dihydroorotate levels and unbound plasma drug levels after treatment with the inhibitor. Based on preclinical data presented herein we plan to start clinical investigations of BAY 2402234 in patients with DLBCL in early 2019. Citation Format: Ashley Eheim, Sven Christian, Hanna Meyer, Detlef Stoeckigt, Claudia Merz, Katja Zimmermann, Marcus Bauser, Andrea Haegebarth, Steven Ferrara, David B. Sykes, David T. Scadden, Stefan Gradl, Andreas Janzer. BAY 2402234: Preclinical evaluation of a novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of diffuse large B-cell lymphoma (DLBCL) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 3597.",
  "authors": [
    {
      "display_name": "Ashley Eheim",
      "id": "A5061973032",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Ashley Eheim"
    },
    {
      "display_name": "Sven Christian",
      "id": "A5056835247",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Sven Christian"
    },
    {
      "display_name": "Hanna Meyer",
      "id": "A5071672332",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Hanna Meyer"
    },
    {
      "display_name": "Detlef Stoeckigt",
      "id": "A5112443721",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Detlef Stoeckigt"
    },
    {
      "display_name": "Claudia Merz",
      "id": "A5039060488",
      "orcid": "https://orcid.org/0009-0008-6380-0335",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Claudia Merz"
    },
    {
      "display_name": "Katja Zimmermann",
      "id": "A5022297061",
      "orcid": "https://orcid.org/0000-0002-3356-8757",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Katja Zimmermann"
    },
    {
      "display_name": "Marcus Bauser",
      "id": "A5074638741",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Marcus Bauser"
    },
    {
      "display_name": "Andrea Haegebarth",
      "id": "A5020529398",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Andrea Haegebarth"
    },
    {
      "display_name": "Steven Ferrara",
      "id": "A5051824746",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Steven Ferrara"
    },
    {
      "display_name": "David B. Sykes",
      "id": "A5088797237",
      "orcid": "https://orcid.org/0000-0002-9788-0221",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "David B. Sykes"
    },
    {
      "display_name": "David T. Scadden",
      "id": "A5083648953",
      "orcid": "https://orcid.org/0000-0001-9821-7133",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "David T. Scadden"
    },
    {
      "display_name": "Stefan Gradl",
      "id": "A5005190013",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Stefan Gradl"
    },
    {
      "display_name": "Andreas Janzer",
      "id": "A5084001403",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Andreas Janzer"
    }
  ],
  "publication_year": 2019,
  "publication_date": "2019-07-01",
  "type": "article",
  "cited_by_count": 1,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S168522863",
    "display_name": "Cancer Research",
    "issn_l": "0008-5472",
    "issn": [
      "0008-5472",
      "1538-7445"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320273"
  },
  "volume": "79",
  "issue": "13_Supplement",
  "first_page": "3597",
  "last_page": "3597",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C2779865431",
      "display_name": "Dihydroorotate dehydrogenase",
      "level": 3,
      "score": 0.7538126
    },
    {
      "id": "C502942594",
      "display_name": "Cancer research",
      "level": 1,
      "score": 0.63229215
    },
    {
      "id": "C207001950",
      "display_name": "In vivo",
      "level": 2,
      "score": 0.5454016
    },
    {
      "id": "C2779338263",
      "display_name": "Lymphoma",
      "level": 2,
      "score": 0.5217953
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.450727
    },
    {
      "id": "C2778559949",
      "display_name": "Diffuse large B-cell lymphoma",
      "level": 3,
      "score": 0.43570784
    },
    {
      "id": "C86803240",
      "display_name": "Biology",
      "level": 0,
      "score": 0.4281491
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.42077345
    },
    {
      "id": "C203014093",
      "display_name": "Immunology",
      "level": 1,
      "score": 0.25039637
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.23118919
    },
    {
      "id": "C181199279",
      "display_name": "Enzyme",
      "level": 2,
      "score": 0.21236184
    },
    {
      "id": "C55493867",
      "display_name": "Biochemistry",
      "level": 1,
      "score": 0.1474325
    },
    {
      "id": "C54355233",
      "display_name": "Genetics",
      "level": 1,
      "score": 0.072411865
    }
  ],
  "topics": [
    {
      "id": "T12827",
      "display_name": "Biochemical and Molecular Research",
      "score": 0.9999
    },
    {
      "id": "T12823",
      "display_name": "Adolescent and Pediatric Healthcare",
      "score": 0.9658
    },
    {
      "id": "T10526",
      "display_name": "HIV/AIDS drug development and treatment",
      "score": 0.9588
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1158/1538-7445.am2019-3597",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T14:42:29.002582",
  "source_database": "OpenAlex"
}